EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience

Muhammer Ergenç iD, Hilmi Yazıcı iD, Furkan Yılmaz, Ahmet Akmercan, Alisina Bulut, Şakir Karpuz, Mümin Coşkun, Emine Bozkurtlar, T Kıvılcım Uprak, Ali Emre Atıcı, M Ümit Uğurlu, Asım Cingi und 2 weitere

Cancer Control · 2026-04 · 33

DOI: 10.1177/10732748261445229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Control, online erschienen am 17.04.2026. Verfasst von Muhammer Ergenç und 13 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Endocrine Surgery Unit, Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Intestinal Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of neoplasms with increasing incidence and variable clinical characteristics. This study aimed to describe the clinicopathological characteristics of surgically/endoscopically treated GEP-NETs and identify prognostic factors associated with overall survival (OS) in a single tertiary center.

Methods

In this retrospective, single-center cohort study, we reviewed the data of adult patients diagnosed with GEP-NETs and treated at the Department of General Surgery, Marmara University School of Medicine, between January 2018 and December 2024. Demographic, clinical, and pathological variables were collected, including histologic type (NET vs. NEC), tumor grade, tumor size, Ki-67 index, mitotic index, nodal status, and stage. The OS was analyzed using the Kaplan–Meier method and compared using the log-rank test. Cox proportional hazards models were used to identify the independent mortality predictors.

Results

Among the 96 patients included in the final analysis, 55% were female, with a median age of 55 years. The primary tumor sites were the pancreas (46%) and stomach (35%), followed by the appendix (6%), small intestine (5%), colorectal (3%), and hepatobiliary tract (4%). Surgical resection and lymph node dissection were performed in 90% and 72% of patients, respectively. NET and NEC accounted for 71% and 29%, respectively. Grades were G1 (48%), G2 (22%), G3 (16%), MiNEN (8%), and undefined (6%). The 5-year OS for the cohort was 79%. Patients with pancreatic and gastric tumors, higher-grade tumors, larger tumors, elevated Ki-67/mitotic indices, NEC histology, and advanced stage had significantly worse survival. In the multivariate analysis, older age, NEC histology, and advanced stage remained independent adverse prognostic factors.

Conclusion

In this single-center experience, GEP-NET prognosis was primarily driven by age, histologic type, and disease stage. These findings may support risk-adapted, multidisciplinary management tailored to tumor biology and disease extent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatic NeoplasmsIntestinal NeoplasmsStomach NeoplasmsHumansFemalePrognosisMiddle AgedRetrospective StudiesMaleAdultAged

Stichwörter der Autor:innen

Ki-67 proliferation indexgastroenteropancreatic neuroendocrine tumorsneuroendocrine neoplasmsneuroendocrine tumorsprognostic factors

Autor:innen und Institutionen

  • Breast and Endocrine Surgery Unit, Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey.
  • Department of General Surgery, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
  • Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey.
  • Department of Pathology, Marmara University School of Medicine, Istanbul, Turkey.

ORCID-Profile: Muhammer Ergenç, Hilmi Yazıcı

Zitieren

APA

Ergenç, M., Yazıcı, H., Yılmaz, F., Akmercan, A., Bulut, A., Karpuz, Ş., Coşkun, M., Bozkurtlar, E., Uprak, T. K., Atıcı, A. E., Uğurlu, M. Ü., Cingi, A., Günal, Ö., & Yeğen, C. (2026). Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience. Cancer Control, 33. https://doi.org/10.1177/10732748261445229

Vancouver

Ergenç M, Yazıcı H, Yılmaz F, Akmercan A, Bulut A, Karpuz Ş, et al. Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience. Cancer Control. 2026;33. doi:10.1177/10732748261445229

BibTeX
@article{Ergen2026,
  author = {Ergenç, Muhammer and Yazıcı, Hilmi and Yılmaz, Furkan and Akmercan, Ahmet and Bulut, Alisina and Karpuz, Şakir and Coşkun, Mümin and Bozkurtlar, Emine and Uprak, T Kıvılcım and Atıcı, Ali Emre and Uğurlu, M Ümit and Cingi, Asım and Günal, Ömer and Yeğen, Cumhur},
  title = {Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience},
  journal = {Cancer Control},
  year = {2026},
  volume = {33},
  doi = {10.1177/10732748261445229}
}
Kostenlos starten →